Varonis Systems
VRNS · NASDAQ
About VRNS
- Employees
- 2,658
- Headquarters
- Miami, Florida
- Listed
- Feb 28, 2014
- Sector
- Information Technology
- Industry
- Software
- Website
- varonis.com
VRNS key statistics
- Market cap
- 5.60B
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 3.56M
- Volume
- 6.49M
- Open price
- $48.69
- High today
- $48.74
- Low today
- $48.66
- 52 Week high
- $63.80
- 52 Week low
- $19.70
Varonis Systems (VRNS) at a glance
Varonis Systems (VRNS) last traded at $48.68, with a market cap of 5.60B and a price-to-earnings ratio of 0.00.
Today the stock has traded between $48.66 and $48.74. The current price is 0.0% above the day's low and 0.1% below its high.
Volume so far is 6.49M shares, above the average of 3.56M shares a day.
Over the past year Varonis Systems has ranged from $19.70 to $63.80, and now sits 66% of the way up that range.
Varonis Systems met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.04 per share against an estimate of $0.0088.
The average analyst price target is $52.19, 7.2% above the current price, from 24 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy37.5%
- Hold62.5%
- Sell0.0%
- Low
- $28.85
- Now
- $48.68
- High
- $63.00
VRNS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 141.3% on average.
- Q3 FY24: reported $0.10 per share against an estimate of $0.0751
- Q4 FY24: reported $0.18 per share against an estimate of $0.1409
- Q1 FY25: reported $0.01 per share against an estimate of -$0.0479
- Q2 FY25: reported $0.03 per share against an estimate of $0.0088
- Q3 FY25: reported $0.06 per share against an estimate of $0.0595
- Q4 FY25: reported $0.08 per share against an estimate of $0.0331
- Q1 FY26: reported $0.06 per share against an estimate of -$0.0544
- Q2 FY26: reported $0.04 per share against an estimate of $0.0088
VRNS news
- Press releaseGlobe Newswire
- Press releaseBusiness Wire
Varonis Systems Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varonis Systems, Inc. - VRNS
- Avi Kapoor
5 Stocks In The Spotlight Last Week: Wall Street's Most Accurate Analysts Weigh In
- Press releasePRNewswire
Are CCC, PAG, VRNS Obtaining Fair Deals for their Shareholders?
- Akanksha Bakshi
Varonis to Go Private in $6.3 Billion Takeover
- Press releasePRNewswire
VRNS SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES VARONIS SYSTEMS, INC.
- Press releaseBusiness Wire
VRNS Stock Alert: Halper Sadeh LLC is Investigating Whether Varonis Systems, Inc. is Obtaining a Fair Price for its Shareholders
- Press releaseGlobe Newswire
Proofpoint to Acquire Varonis in a $6.3 Billion Transaction
Similar companies
Companies in the same industry as Varonis Systems
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.